These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6228466)

  • 1. Hepatitis B vaccine: immunization of children and newborns in an endemic area (Senegal).
    Coursaget P; Chiron JP; Barin F; Goudeau A; Yvonnet B; Denis F; Correa P; N'Doye R; Diop-Mar I
    Dev Biol Stand; 1983; 54():245-57. PubMed ID: 6228466
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive and active immunoprophylaxis of hepatitis B.
    Seeff LB; Koff RS
    Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

  • 5. Active immunization against hepatitis B in an area of high endemicity. Part II: Prevention of early infection of the child.
    Maupas P; Chiron JP; Goudeau A; Coursaget P; Perrin J; Barin F; Denis F; Diop Mar I
    Prog Med Virol; 1981; 27():185-201. PubMed ID: 7232761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vaccination against hepatitis B in Senegal].
    Diop Mar J
    Bull Acad Natl Med; 1982 Mar; 166(3):353-9. PubMed ID: 6751481
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses].
    Corbella E; Garghetti L; Poloniato A; Zambelloni C; Consonni A
    Minerva Pediatr; 1987 Oct; 39(20):821-6. PubMed ID: 2963953
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis B infection in infantile population of Sénégal].
    Sall Diallo A; Sarr M; Fall Y; Diagne C; Kane MO
    Dakar Med; 2004; 49(2):136-42. PubMed ID: 15786625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoprevention of hepatitis B in children].
    Kätzner K; Laufs R
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):124-5. PubMed ID: 6727883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexposure prophylaxis of hepatitis B. Recommendations of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1984 Sep; 101(3):351-4. PubMed ID: 6235762
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unit.
    Nivet H; Drucker J; Dubois F; Goudeau A; Coursaget P; Rolland JC; Grenier B; Maupas P
    Int J Pediatr Nephrol; 1982 Mar; 3(1):25-8. PubMed ID: 7107116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).
    Coursaget P; Yvonnet B; Chotard J; Sarr M; Vincelot P; N'doye R; Diop-Mar I; Chiron JP
    Lancet; 1986 Nov; 2(8516):1143-5. PubMed ID: 2877284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of viral hepatitis].
    Anzai T
    Hokkaido Igaku Zasshi; 1984 May; 59(3):244-6. PubMed ID: 6479843
    [No Abstract]   [Full Text] [Related]  

  • 19. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
    Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
    J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.